HuGE Literature Finder
Records 1-30
|
A comprehensive prognostic analysis of osimertinib treatment in advanced non-small cell lung cancer patients with acquired EGFR-T790M mutation: a real-world study.
Journal of cancer research and clinical oncology 2021 Sep . Tang Xin, Li Yuan, Qian Wen-Lei, Yan Wei-Feng, Pang Tong, Gong You-Ling, Yang Zhi-Ga |
|
Associations of polycyclic aromatic hydrocarbons exposure and its interaction with XRCC1 genetic polymorphism with lung cancer: A case-control study.
Environmental pollution (Barking, Essex : 1987) 2021 Sep 290 118077. Zhou Shuang, Zhu Qiuqi, Liu Huimin, Jiang Shunli, Zhang Xu, Peng Cheng, Yang Guanlin, Li Jiaoyuan, Cheng Liming, Zhong Rong, Zeng Qiang, Miao Xiaoping, Lu Qi |
|
Establishment of non-small-cell lung cancer risk prediction model based on prognosis-associated ADME genes.
Bioscience reports 2021 Sep . Han Ke, Wang Jukun, Qian Kun, Zhao Teng, Zhang |
|
K
Scientific reports 2021 Sep 11 (1): 18330. Glaser Felix, Hundehege Petra, Bulk Etmar, Todesca Luca Matteo, Schimmelpfennig Sandra, Nass Elke, Budde Thomas, Meuth Sven G, Schwab Albrec |
|
The effect of CHRNA3 rs1051730 C>T and ABCB1 rs3842 A>G polymorphisms on non-small cell lung cancer and nicotine dependence in Iranian population.
Heliyon 2021 Sep 7 (9): e07867. Veiskarami Parisa, Houshmand Massoud, Seifi Sharareh, Ansarinejad Nafiseh, Fardad Farshid, Abbasi Bahar |
|
A phase II study of osimertinib for radiotherapy-naïve CNS metastasis from non-small cell lung cancer: Results for the T790M cohort of the OCEAN study (LOGIK1603/WJOG9116L).
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2021 Aug . Yamaguchi Hiroyuki, Wakuda Kazushige, Fukuda Minoru, Kenmotsu Hirotsugu, Mukae Hiroshi, Ito Kentaro, Chibana Kenji, Inoue Kohji, Miura Satoru, Tanaka Kentaro, Ebi Noriyuki, Suetsugu Takayuki, Harada Taishi, Kirita Keisuke, Yokoyama Toshihide, Nakatani Yuki, Yoshimura Kenichi, Nakagawa Kazuhiko, Yamamoto Nobuyuki, Sugio Ken |
|
Co-mutations of epidermal growth factor receptor and BRAF in Chinese non-small cell lung cancer patients.
Annals of translational medicine 2021 Aug 9 (16): 1321. Peng Panli, Lv Guoli, Hu Jinwei, Wang Kai, Lv Junhong, Guo Ga |
|
Decreased Thrombospondin-1 and Bone Morphogenetic Protein-4 Serum Levels as Potential Indices of Advanced Stage Lung Cancer.
Journal of clinical medicine 2021 Aug 10 (17): . Kosacka Monika, Dy?a Tomasz, Chaszczewska-Markowska Monika, Bogunia-Kubik Katarzyna, Brzecka An |
|
EGFR-plasma mutations in prognosis for non-small cell lung cancer treated with EGFR TKIs: A meta-analysis.
Cancer reports (Hoboken, N.J.) 2021 Aug e1544. Phan Thang Thanh, Tran Vinh Thanh, Tran Bich-Thu, Ho Toan Trong, Pho Suong Phuoc, Le Anh Tuan, Le Vu Thuong, Nguyen Hang Thuy, Nguyen Son Truo |
|
Genomic alteration profiles of lung cancer and their relationship to clinical features and prognosis value using individualized genetic testing.
Journal of thoracic disease 2021 Aug 13 (8): 5007-5015. Zhang Fan, Wang Junyan, Ma Minting, Xu Yu, Lu Xiangjun, Wei Su |
|
Identification of predictors for brain metastasis in newly diagnosed non-small cell lung cancer: a single-center cohort study.
European radiology 2021 Aug . Park Sohee, Lee Sang Min, Ahn Yura, Kim Minjae, Suh Chong Hyun, Do Kyung-Hyun, Seo Joon Be |
|
Immune-Omics Networks of
Cancers 2021 Aug 13 (17): . Ye Qing, Singh Salvi, Qian Peter R, Guo Nancy L |
|
PD-L1 expression, EGFR and KRAS mutations and survival among stage III unresected non-small cell lung cancer patients: a Danish cohort study.
Scientific reports 2021 Aug 11 (1): 16892. Cronin-Fenton Deirdre, Dalvi Tapashi, Movva Naimisha, Pedersen Lars, Hansen Hanh, Fryzek Jon, Hedgeman Elizabeth, Mellemgaard Anders, Rasmussen Torben R, Shire Norah, Hamilton-Dutoit Stephen, Nørgaard Met |
|
Survival of Patients with Epidermal Growth Factor Receptor-Mutated Metastatic Non-Small Cell Lung Cancer Treated beyond the Second Line in the Tyrosine Kinase Inhibitor Era.
Cancers 2021 Aug 13 (15): . Refeno Valéry, Lamuraglia Michele, Terrisse Safae, Bonnet Clément, Dumont Clément, Doucet Ludovic, Pouessel Damien, Culine Stepha |
|
The association of TAP polymorphisms with non-small-cell lung cancer in the Han Chinese population.
Human immunology 2021 Aug . Liu Weipeng, Ma Qianli, Li Chuanyin, Li Yingfu, Liu Shuyuan, Shi Li, Yao Yufe |
|
Bevacizumab plus erlotinib in Chinese patients with untreated, EGFR-mutated, advanced NSCLC (ARTEMIS-CTONG1509): A multicenter phase 3 study.
Cancer cell 2021 Jul . Zhou Qing, Xu Chong-Rui, Cheng Ying, Liu Yun-Peng, Chen Gong-Yan, Cui Jiu-Wei, Yang Nong, Song Yong, Li Xiao-Ling, Lu Shun, Zhou Jian-Ying, Ma Zhi-Yong, Yu Shi-Ying, Huang Cheng, Shu Yong-Qian, Wang Zhen, Yang Jin-Ji, Tu Hai-Yan, Zhong Wen-Zhao, Wu Yi-Lo |
|
Comprehensive assessment of PD-L1 expression, tumor mutational burden and oncogenic driver alterations in non-small cell lung cancer patients treated with immune checkpoint inhibitors.
Lung cancer (Amsterdam, Netherlands) 2021 Jul 159 128-134. Yoh Kiyotaka, Matsumoto Shingo, Furuya Naoki, Nishino Kazumi, Miyamoto Shingo, Oizumi Satoshi, Okamoto Norio, Itani Hidetoshi, Kuyama Shoichi, Nakamura Atsushi, Nishi Koichi, Fukuda Ikue, Tsuta Koji, Hayashi Yuichiro, Motoi Noriko, Ishii Genichiro, Goto Koic |
|
Efficacy of osimertinib for preventing leptomeningeal metastasis derived from advanced EGFR-mutated non-small cell lung cancer: a propensity-matched retrospective study.
BMC cancer 2021 Jul 21 (1): 873. Wang Xia, Cai Jing, Zeng Zhimin, Liu Anw |
|
Frequency of actionable molecular drivers in lung cancer patients with precocious brain metastases.
Clinical neurology and neurosurgery 2021 Jul 208 106841. Hanke Benjamin, Jünger Stephanie T, Kirches Elmar, Waldt Natalie, Schreiber Jens, Lücke Eva, Franke Sabine, Sandalcioglu I Erol, Warnke Jan-Peter, Meisel Hans-Jörg, Prell Julian, Scheller Christian, Braunsdorf Werner E K, Preusser Matthias, Schildhaus Hans-Ulrich, Mawrin Christi |
|
Study of Programmed Death Ligand 1 and EGFR/HER2 Expression in Non-Small-Cell Lung Carcinoma With a Clinicopathological Spectrum.
Cureus 2021 Jul 13 (7): e16195. Laishram Devina, Raphael Vandana, Marbaniang Evarisalin, Harris Caleb, Jagtap Vikas, Wankhar Baphiraly |
|
Lung cancer in the older population:Interactive effects of angiotensin converting enzyme gene polymorphism (rs 4340 ID) and tobacco addiction in risk assessment.
Indian journal of cancer 2021 Jun . Banerjee Joyita, Gupta Abhishek, Agnihotri Vertica, Pradhan Rashmita, Kandel Ramesh, Upadhyay Ashish D, Dwivedi Sadanand, Kumar Lalit, Dey Sharmistha, Dey Aparajit |
|
An Observational Study to Assess the Molecular Epidemiology and Direct Medical Costs of Epidermal Growth Factor Receptor (EGFR) Mutations in Patients with Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer Treated with Afatinib in Real-World Clinical Settings in Greece.
Lung Cancer (Auckland, N.Z.) 2021 12 93-102. Mountzios Giannis, Lampaki Sofia, Koliou Georgia-Angeliki, Vozikis Athanassios, Kontogiorgos Ioannis, Papantoniou Panagiotis, Koufaki Margarita-Ioanna, Res Eleni, Boutis Anastasios, Christopoulou Athina, Pastelli Nicoleta, Grivas Anastasios, Aravantinos Gerasimos, Lalla Efthalia, Oikonomopoulos Georgios, Koumarianou Anna, Spyratos Dionisios, Bafaloukos Dimitrios, Rigakos Georgios, Papakotoulas Pavlos, Fountzilas George, Linardou Hele |
|
Genomic Profiling of Circulating Tumor DNA from Patients with Extensive-Stage Small Cell Lung Cancer Identifies Potentially Actionable Alterations.
Journal of Cancer 2021 12 (17): 5099-5105. Yang Jing, Wang Xiangyun, Lu Jingli, Chen Hui, Zhao Xiaochen, Gao Chan, Bai Yuezong, Zhang Qiwen, Fu Xiaomin, Zhang Xiaoji |
|
Investigation of Causal Effect of Type 2 Diabetes Mellitus on Lung Cancer: A Mendelian Randomization Study.
Frontiers in genetics 2021 12 673687. Hong Tongtong, Qin Na, Zhao Xiaoyu, Wang Cheng, Jiang Yue, Ma Hongxia, Dai Junche |
|
KEAP1/NFE2L2 Mutations of Liquid Biopsy as Prognostic Biomarkers in Patients With Advanced Non-Small Cell Lung Cancer: Results From Two Multicenter, Randomized Clinical Trials.
Frontiers in oncology 2021 11 659200. Zhu Hongyuan, Xie Daipeng, Yu Yunfang, Yao Lintong, Xu Bin, Huang Luyu, Wu Shaowei, Li Fasheng, Zheng Yating, Liu Xinyi, Xie Wenzhuan, Huang Mengli, Li Hao, Zheng Shaopeng, Zhang Dongkun, Qiao Guibin, Chan Lawrence W C, Zhou Hai |
|
Prognosis of Non-small-cell Lung Cancer Patients With Lipid Metabolism Pathway Alternations to Immunotherapy.
Frontiers in genetics 2021 12 646362. Cheng Tianli, Zhang Jing, Liu Danni, Lai Guorong, Wen Xiaopi |
|
Prospective Exploratory Analysis of Angiogenic Biomarkers in Peripheral Blood in Advanced NSCLC Patients Treated With Bevacizumab Plus Chemotherapy: The ANGIOMET Study.
Frontiers in oncology 2021 11 695038. Jantus-Lewintre Eloisa, Massutí Sureda Bartomeu, González Larriba José Luis, Rodríguez-Abreu Delvys, Juan Oscar, Blasco Ana, Dómine Manuel, Provencio Pulla Mariano, Garde Javier, Álvarez Rosa, Maestu Inmaculada, Pérez de Carrión Ramón, Artal Ángel, Rolfo Christian, de Castro Javier, Guillot Mónica, Oramas Juana, de Las Peñas Ramón, Ferrera Lioba, Martínez Natividad, Serra Òlbia, Rosell Rafael, Camps Carl |
|
The Predictive Values of Advanced Non-Small Cell Lung Cancer Patients Harboring Uncommon
Frontiers in oncology 2021 11 646577. Tan Jiarong, Hu Chengping, Deng Pengbo, Wan Rongjun, Cao Liming, Li Min, Yang Huaping, Gu Qihua, An Jian, Jiang Ju |
|
Treatment and Prognosis of Solid and Cystic Brain Metastases in Patients with Non-Small-Cell Lung Cancer.
Cancer management and research 2021 13 6309-6317. Xu Yi-Bing, Zhang Yiping, Song Zhengbo, Wang Wenxian, Shao L |
|
Association of hypoxia-inducible factor-1? polymorphisms with susceptibility to nonsmall-cell lung cancer: A summative analysis.
Journal of cancer research and therapeutics 0 17 (4): 1134-1135. Sookaromdee Pathum, Wiwanitkti Vir |
- Page last reviewed:Oct 1, 2020
- Page last updated:Sep 22, 2021
- Content source: